The Association Between Sarcoidosis and Malignancy: A Comprehensive Population-Based Cohort Study
Authors:
- Yonatan Shneor PattYPYonatan Shneor Patt
- Niv Ben-ShabatNBNiv Ben-Shabat
- Kassem SharifKSKassem Sharif
- Chen PattCPChen Patt
- Yoav ElizurYEYoav Elizur
- Mohamad ArowMAMohamad Arow
- Arnon D. CohenACArnon D. Cohen
- Abdulla WatadAbdulla Watad
- Dennis McGonagleDMDennis McGonagle
- Howard AmitalHAHoward Amital
- Paula DavidPDPaula David
Open Access
- 22 November 2024
- journal article
- research article
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 13 (23) , 7045
Abstract
Background: Sarcoidosis is a multisystem granulomatous disorder with a variable clinical course and complications. The relationship between sarcoidosis and malignancies remains unclear, including specific malignancy associations with sarcoidosis and whether the association is short-term, long-term, or a result of misdiagnoses or coincidence. This study investigated the association between sarcoidosis and malignancy by analyzing the varying intervals between the diagnoses of these two conditions to clarify their inter-relationship. Methods: This retrospective cohort study included almost 24,000 sarcoidosis patients and matched controls at a 1:5 ratio in patients diagnosed between 2000 and 2015 in Israel. Patients had a median age of 57 years. Malignancy rates were compared across several timeframes: overall, within one year before or after sarcoidosis diagnosis and more than one year. Logistic regression models were employed to estimate odds ratios for the association between sarcoidosis and malignancy, adjusting for sociodemographic and clinical variables. Results: Sarcoidosis patients had a significantly higher prevalence of malignancies (19.5%) compared to controls (13.6%) (p < 0.001). The association remained significant for both hematologic malignancies (OR: 2.94, 95% CI: 2.41–3.57) and solid malignancies (OR: 1.41, 95% CI: 1.27–1.55). The strongest association was observed with lymphoma, particularly within the first year of sarcoidosis diagnosis (OR: 14.88, 95% CI: 8.83–25.1). Elevated odds for malignancies persisted both within one year and beyond, including sarcoma and soft tissue cancers and genitourinary malignancies. Conclusions: Our study confirms a significant association between sarcoidosis and both hematologic and solid malignancies in both the short and long term across various timeframes. These findings emphasize the need for increased clinical vigilance in sarcoidosis patients and highlight the importance of further research into the shared genetic and environmental mechanisms that may underlie this relationship.Keywords
This publication has 43 references indexed in Scilit:
- Immune checkpoint inhibitor–associated sarcoidosis: A usually benign disease that does not require immunotherapy discontinuationEuropean Journal of Cancer, 2021
- Are infectious diseases risk factors for sarcoidosis or a result of reverse causation? Findings from a population-based nested case–control studyEuropean Journal of Epidemiology, 2020
- The long-term prognostic significance of sarcoidosis-associated pulmonary hypertension – A cohort studyClinical Immunology, 2019
- Sarcoidosis-Like Reactions Induced by Checkpoint InhibitorsJournal of Thoracic Oncology, 2018
- Risk of Malignancy Among Patients With Sarcoidosis: A Population‐Based Cohort StudyArthritis Care & Research, 2016
- Sarcoidosis and the occurrence of malignant diseasesRheumatology International, 2014
- Sarcoidosis and testicular cancer: A case series and literature reviewUrologic Oncology: Seminars and Original Investigations, 2010
- The incidence of cancer in patients with idiopathic pulmonary fibrosis and sarcoidosis in the UKRespiratory Medicine, 2007
- Sarcoidosis and malignancyClinics in Dermatology, 2007
- Neoplasia in the etiology of sarcoidosisEuropean Journal of Internal Medicine, 2006